Clinical Decision Making Using Pharmacokinetic and Pharmacodynamic Data

  • B. Whiting
  • A. W. Kelman

Abstract

Decision making is an extremely important part of clinical practice. It is integral to the formulation of policies which determine the rational approach to investigation, diagnosis and treatment. As this chapter will focus on the use of pharmacokinetic and pharmacodynamic data in clinical decision making, investigation and diagnosis will receive little attention, and emphasis will be placed on relevant aspects of drug treatment.

Keywords

Half Life Lidocaine Digoxin Theophylline Carbamazepine 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Beal, S. L., and Sheiner, L. B., 1979, “NONMEM Users Guide, part I”, Technical Report, Division of Clinical Pharmacology, University of California, San Francisco.Google Scholar
  2. Beal, S. L., and Sheiner, L. B., 1980, “NONMEM Users Guide, part II”, Technical Report, Division of Clinical Pharmacology, University of California, San Francisco.Google Scholar
  3. Benet, L. Z., and Sheiner, L. B., 1980, Design and optimisation of dosage regimens, in: “The Pharmacological Basis of Therapeutics”, 6th edition, A. G. Gilman, L. S. Goodman and A. Gilman, eds., Macmillan, London: 1675.Google Scholar
  4. Brunswick, D. J., Amsterdam, J. D., Mendel, J., and Stern, S. L., 1979, Prediction of steady state imipramine and desmethylimi- pramine plasma concentrations from single dose data, Clin. Pharmacol. Ther., 25: 605.PubMedGoogle Scholar
  5. Chiou, W. L., Gadalla, M. A. F., and Peng, W. P., 1978, Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant- rate intravenous infusion, J. Pharmacokinet. Biopharm., 6: 135.PubMedCrossRefGoogle Scholar
  6. Cooper, T. B., Bergner, P. E. E., and Simpson, G. M., 1973, The 24-hour serum lithium level as a progncsticator of dosage requirements, Am. J. Psychiatry, 130: 601.PubMedGoogle Scholar
  7. Cooper, T. B., and Simpson, G. M., 1978, Prediction of individual dosage of nortriptyline, Am. J. Psychiatry, 135: 333.PubMedGoogle Scholar
  8. D’Argenio, D. Z., 1981, Optimal sampling times for pharmacokinetic experiments, J. Pharmacokinet. Biopharm., 9: 739.PubMedCrossRefGoogle Scholar
  9. Endrenyi, L., 1981, Design of experiments for estimating enzyme and pharmacokinetic experiments, in: “Kinetic Data Analysis: Design and Analysis of Enzyme and Pharmacokinetic Experiments”, L. Endrenyi, ed., Plenum, London: 137.Google Scholar
  10. Fotheringham, G. H., Whiting, B., Kelman, A. W., and Bryson, S. M., 1982, Evaluation of kinetic parameter estimation from routine clinical pharmacokinetic data, Br. J. Clin. Pharmacol., 14: 595.Google Scholar
  11. Gibaldi, M., and Levy, G., 1976, Pharmacokinetics in clinical practice. 1 Concepts, JAMA, 235: 1864.PubMedCrossRefGoogle Scholar
  12. Gibaldi, M., and Perrier, P., 1975, “Pharmacokinetics”, Marcel Dekker, New York.Google Scholar
  13. Hill, A. V., 1910, The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves, J. Physiol. (Lond.), 40: iv.Google Scholar
  14. Holford, N. H. G., and Sheiner, L. B., 1981a, Pharmacokinetic and pharmacodynamic modeling in vivo, CRC Critical Reviews in Bioengineering: 273.Google Scholar
  15. Holford, N. H. G., and Sheiner, L. B., 1981b, Understanding the dose- effect relationship: clinical application of pharmacokinetic- pharmacodynamic models, Clin. Pharmacokinet., 6: 429.CrossRefGoogle Scholar
  16. Holford, N. H. G., Coates, P. E., Guentert, T. W., Riegelman, S., and Sheiner, L. B., 1981, The effect of quinidine and its metabolites on the electrocardiogram and systolic time intervals - concentration-response relationships, Br. J. Clin. Pharmacol., 11: 187.PubMedGoogle Scholar
  17. Joel, S. E., Bryson, S. M., Small, M., Hillis, W. S., Kelman, A. W., and Whiting, B., 1983, Kinetic predictive techniques applied to lignocaine therapeutic drug monitoring, Ther. Drug Monit., 5: 271.PubMedCrossRefGoogle Scholar
  18. Kelman, A. W., and Whiting, B., 1980, The modelling of drug response in individual subjects, J. Pharmacokinet. Biopharm., 8: 115.PubMedCrossRefGoogle Scholar
  19. Kelman, A. W., Whiting, B., and Bryson, S. M., 1982a, OPT: a package of computer programs for parameter optimisation in clinical pharmacokinetics, Br. J. Clin. Pharmacol., 14: 247.Google Scholar
  20. Kelman, A. W., Whiting, B., and Struthers, A. D., 1982b, Prediction of bronchodilator response to theophylline in chronic bronchitis Br. J. Clin. Pharmacol., 14: 609.Google Scholar
  21. Koup, J. R., Sack, C.M., Smith, A. L., and Gibaldi, M., 1979, Hypothesis for the individualisation of drug dosage, Clin. Pharmacokinet., 4: 460.PubMedCrossRefGoogle Scholar
  22. Landaw, E. M., 1980, “Optimal Experimental Design for Biologic Com- partmental Systems with Applications to Pharmacokinetics”, Ph.D. Thesis, UCLA, University Microfilms International.Google Scholar
  23. Landaw, E. M., 1982, Optimal microcompartmental sampling designs for parameter estimation: practical aspects of the identification problem, Math. Comput. Simul., xxiv: 525.Google Scholar
  24. Lennert, L., Peck, C. C., Vozeh, S., and Follath, F., 1982, Lidocaine Forecaster: a two-compartment Bayesian patient pharmacokinetic program, Clin. Pharmacol. Ther., 31: 243.Google Scholar
  25. Montgomery, S. A., McAuley, R., Montgomery, D. B., Braithwaite, R. A. and Dawling, S., 1979, Dosage adjustment from single nortriptyline spot level predictor tests in depressed patients, Clin. Pharmacokinet., 4: 129.PubMedCrossRefGoogle Scholar
  26. Nelder, J. A., and Mead, R., 1965, A simplex method for function minimisation, Comput. J., 7: 308.Google Scholar
  27. Peck, C. C., Brown, D. D., Sheiner, L. B., and Schuster, B. G., 1980, A microcomputer drug (theophylline) dosing program which assists and teaches physicians, in: “Proc. 4th Annual Conf. on Computers in Medical Care”, J. T. O’Neill, ed., vol. 2: 988.Google Scholar
  28. Richens, A., and Marks, V., 1981, “Therapeutic Drug Monitoring”, Churchill Livingstone, Edinburgh.Google Scholar
  29. Sheiner, L. B., Rosenberg, B. G., and Marathe, V. V., 1977, Estimation of population characteristics of pharmacokinetic parameters from routine data, J. Pharmacokinet. Biopharm., 5: 445.PubMedCrossRefGoogle Scholar
  30. Sheiner, L. B., Beal, S. L., Rosenberg, B., and Marathe, V. V., 1979a, Forecasting individual pharmacokinetics, Clin. Pharmacol. Ther., 26: 294.Google Scholar
  31. Sheiner, L. B., Stanski, D. R., Vozeh, S., Miller, R. D., and Ham, J., 1979b, Simultaneous modelling of pharmacokinetics and dynamics: application to d-tubocurarine, Clin. Pharmacol. Ther., 25: 358.Google Scholar
  32. Sheiner, L. B., and Beal, S. L., 1982, Bayesian individualization of pharmacokinetics: simple implementation and comparison with non-Bayesian methods, J. Pharm. Sci., 71: 1344.PubMedCrossRefGoogle Scholar
  33. Slattery, J. T., Gibaldi, M., and Koup, J. R., 1980, Prediction of drug concentration at steady state from a single determination of concentration after an initial dose, Clin. Pharmacokinet., 5: 377.PubMedCrossRefGoogle Scholar
  34. Slattery, J. T., 1981, Single-point maintenance dose prediction: role of interindividual differences in clearance and volume of distribution in choice of sampling times, J. Pharm. Sci., 70: 1174.PubMedCrossRefGoogle Scholar
  35. Unadkat, J. D., and Rowland, M., 1981, Some considerations of the “single-point single-dose” method for predicting individual dosage requirements, in: “Proc. 1st European Congress of Bio- pharmaceutics and Pharmacokinetics”, Clermont Ferrand, vol. 3: 321.Google Scholar
  36. Unadkat, J. D., and Rowland, M., 1982, Further considerations of the “single-point single-dose” method to estimate individual maintenance dosage requirements, Ther. Drug Monit., 4: 201.PubMedCrossRefGoogle Scholar
  37. Vozeh, S., Muir, K. T., Sheiner, L. B., and Follath, F., 1981, Predicting individual phenytoin dosage, J. Pharmacokinet. Biopharm., 9: 131.PubMedCrossRefGoogle Scholar
  38. Whiting, B., Holford, N. H. G., and Sheiner, L. B., 1980, Quantitative analysis of the disopyramide concentration-effect relationship, Br. J. Clin. Pharmacol., 9: 67.PubMedGoogle Scholar
  39. Whiting, B., Kelman, A. W., Addis, G. J., and Barclay, J., 1981, Modelling theophylline response in individual patients with chronic bronchitis, Br. J. Clin. Pharmacol., 12: 481.PubMedGoogle Scholar
  40. Whiting, B., Kelman, A. W., and Struthers, A. D., 1984a, Prediction of response to theophylline in chronic bronchitis, Br. J. Clin. Pharmacol., 17: 1.Google Scholar
  41. Whiting, B., Kelman, A. W., Bryson, S. M., Derkx, F. H. M., Thomson, A. H., Fotheringham, G. H., and Joel, S. E., 1984b, Clinical Pharmacokinetics: a comprehensive system for therapeutic drug monitoring and effective prescribing, Brit. Med. J., 288: 541.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • B. Whiting
  • A. W. Kelman

There are no affiliations available

Personalised recommendations